Chronic Liver Disease Flashcards
(99 cards)
what is the outcome of chronic liver disease
cirrhosis
when does liver disease become chronic
when duration is longer than 6 months- duration may be subclinical
what is the difference between compensated and decompensated chronic liver disease
compensated- patients do not have symptoms relating to their cirrhosis
decompensated- symptomatic complications related to cirrhosis
what are symptomatic complications relating to cirrhosis
jaundice, ascites, variceal haemorrhage, hepatic encephalopathy
why are sinusoidal capillaries leaky
to allow the movement of protein etc
what cells initiate fibrosis and how
hepatocyte kupffer cells/ inflammatory cells cause quiescent hepatic stellate cells to turn into activated HSC which are pro inflammatory and then turn into apoptotic HSC
what are the causes of chronic liver disease (cirrhosis) in order of most common
(the ddx for cirrhosis)
Alcohol, NAFLD, Hepatitis C, Primary Biliary Cholangitis, Autoimmune Hepatitis, Hepatitis B, Haemochromatosis, Primary Sclerosing Cholangitis, Wilsons Disease, alpha 1anti-trypsin, Budd-Chiari, Methotrexate,
what other disease can chronic affect the liver as a bystander
amyloid,
rotor syndrome,
sarcoid
what is NAFLD
fatty liver or steato-hepatits in absence of other cause
what is seen microscopically in NASH
fat globlets, black dots- neutrophils infiltration, collagen/ fibrosis
what is the ‘2 hit; pathogenesis of NASH
1st= excess fat accumulation
2nd= intrahepatic oxidative stress, lipid peroxidation, TNF-alpha; pro inflammatory cytokine cascade, lipopolysaccharide, ischaemia- reperfusion injury
what causes oxidative stress and lipid peroxidation
MCD diets (methionine-choline deficient)
what does the ‘second hit’ activate and lead to
activates NF-kB and the progression of NASH with increased ARE gene expression
what metabolic syndrome factors are associated with NASH/NAFLD
type II diabetes, obesity, HDL cholesterol, hypertension, triglycerides
when NASH is in conjunction with metabolic syndrome what depends what you present with
your genes
what is the treatment for a simple steatosis
weight loss and exercise
what are the risks of simple steatosis
increased cardiovascular risks
what is the treatment for NASH
weight loss and exercise (some experimental treatments)
what is the risk of NASH
progression to cirrhosis
what are the types of auto immune liver disease
primary biliary cholangitis,
auto-immune hepatitis,
primary sclerosing cholangitis,
alcoholic related liver disease (has autoimmune components),
drug reactions
what causes primary biliary cholangitis
autoantibodies (AMA- antimitochondrial antibodies) against mitochondrial antigens (M2-E2 E3 subunits of PGC-E2) in the inner leaflet of the mitochondrian
what mediates PBC
T cell mediates- CD4 cells reactive to M2 target
who is PBC most commonly seen in
women 10;1
what is the presentation of PBC
usually symptomatic/ incidental
symptoms;
- fatigue
- itch without rash
- xanthesalma (around eyelids) and xanthomas